Better Therapeutics Inc
OTC:BTTX

Watchlist Manager
Better Therapeutics Inc Logo
Better Therapeutics Inc
OTC:BTTX
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 5k USD
Section:
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

There is not enough data to reliably calculate the relative value of BTTX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BTTX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

N/A
P/S
P/S
Price to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0.9
Industry
22.6
Forward
-0
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-0
Median 5Y
-1.2
Industry
14.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-0
Median 5Y
-1.1
Industry
21.8
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0
Industry
2.3
More Details
N/A
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.6
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
-1.1
Industry
12
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
-1
Industry
16.6
Forward
-0
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
-1.2
Industry
14.9
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
-1.1
Industry
19
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
vs Industry
Median 3Y
1
Median 5Y
7.2
Industry
1.9
More Details

Multiples Across Competitors

BTTX Competitors Multiples
Better Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Better Therapeutics Inc
OTC:BTTX
5k USD 0 -0 -0 -0
US
Veeva Systems Inc
NYSE:VEEV
48B USD 16.2 59.3 47.8 50.1
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
29.4B AUD 133.5 255.5 176.9 176.9
US
Doximity Inc
NYSE:DOCS
12.5B USD 21.2 53.3 47.3 49.5
JP
M3 Inc
TSE:2413
1.5T JPY 4.9 36.3 18.2 21.8
US
Waystar Holding Corp
NASDAQ:WAY
6.8B USD 6.7 79 20.4 36.5
SE
Sectra AB
STO:SECT B
59.6B SEK 27.9 101.8 -143.7 -143.7
US
Heartflow Inc
NASDAQ:HTFL
3.2B USD 0 0 0 0
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
255.2B INR 0 0 0 0
US
Vocera Communications Inc
F:V00
2.4B EUR 11.9 -328.2 268 4 291.3
P/S Multiple
Revenue Growth P/S to Growth
US
Better Therapeutics Inc
OTC:BTTX
Average P/S: 28.5
Not Available 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
16.2
14%
1.2
US
C
Cerner Corp
LSE:0R00
5.4
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
133.5
28%
4.8
US
Doximity Inc
NYSE:DOCS
21.2
12%
1.8
JP
M3 Inc
TSE:2413
4.9
16%
0.3
US
W
Waystar Holding Corp
NASDAQ:WAY
6.7
12%
0.6
SE
Sectra AB
STO:SECT B
27.9
34%
0.8
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
US
V
Vocera Communications Inc
F:V00
11.9
N/A N/A
P/E Multiple
Earnings Growth PEG
US
Better Therapeutics Inc
OTC:BTTX
Average P/E: 91.2
Negative Multiple: -0 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
59.3
32%
1.9
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
255.5
33%
7.7
US
Doximity Inc
NYSE:DOCS
53.3
18%
3
JP
M3 Inc
TSE:2413
36.3
14%
2.6
US
W
Waystar Holding Corp
NASDAQ:WAY
79
N/A N/A
SE
Sectra AB
STO:SECT B
101.8
14%
7.3
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Better Therapeutics Inc
OTC:BTTX
Average EV/EBITDA: 85.8
Negative Multiple: -0 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
47.8
38%
1.3
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
176.9
32%
5.5
US
Doximity Inc
NYSE:DOCS
47.3
23%
2.1
JP
M3 Inc
TSE:2413
18.2
13%
1.4
US
W
Waystar Holding Corp
NASDAQ:WAY
20.4
19%
1.1
SE
Sectra AB
STO:SECT B
Negative Multiple: -143.7 N/A N/A
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
US
V
Vocera Communications Inc
F:V00
268
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Better Therapeutics Inc
OTC:BTTX
Average EV/EBIT: 667
Negative Multiple: -0 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
50.1
39%
1.3
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
176.9
31%
5.7
US
Doximity Inc
NYSE:DOCS
49.5
24%
2.1
JP
M3 Inc
TSE:2413
21.8
N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
36.5
49%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -143.7 N/A N/A
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
US
V
Vocera Communications Inc
F:V00
4 291.3
N/A N/A

See Also

Summary
BTTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BTTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BTTX stock valuation using valuation multiples.
Wall Street Estimates
BTTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BTTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
NUTX
Nutex Health Inc
Nutex Health Inc is a US-based company operating in Health Care Technology industry.
Undervalued by 43%
TDOC
Teladoc Health Inc
Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Int...
Undervalued by 36%
ICAD
ICAD Inc
iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions.
Overvalued by 71%
SLP
Simulations Plus Inc
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development...
Overvalued by 26%
INSP
Inspire Medical Systems Inc
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with...
Undervalued by 14%
FORA
Forian Inc
Forian, Inc. engages in the provision of healthcare information, analytics and technology services.
Undervalued by 2%
OPRX
OPTIMIZERx Corp
OptimizeRx Corp. is digital health company, engaging in the provision of digital health messaging via electronic health records,...
Overvalued by 47%
STRM
Streamline Health Solutions Inc
Streamline Health Solutions, Inc. engages in the provision of transformational data-driven solutions for healthcare organization...
Undervalued by 52%
NUTX
Nutex Health Inc
Nutex Health Inc is a US-based company operating in Health Care Technology industry.
Undervalued by 43%
TDOC
Teladoc Health Inc
Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Int...
Undervalued by 36%
ICAD
ICAD Inc
iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions.
Overvalued by 71%
SLP
Simulations Plus Inc
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development...
Overvalued by 26%
INSP
Inspire Medical Systems Inc
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with...
Undervalued by 14%
FORA
Forian Inc
Forian, Inc. engages in the provision of healthcare information, analytics and technology services.
Undervalued by 2%
OPRX
OPTIMIZERx Corp
OptimizeRx Corp. is digital health company, engaging in the provision of digital health messaging via electronic health records,...
Overvalued by 47%
STRM
Streamline Health Solutions Inc
Streamline Health Solutions, Inc. engages in the provision of transformational data-driven solutions for healthcare organization...
Undervalued by 52%
Back to Top
ALPHA SPREAD
Follow us
Join more than 292,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.